Gilead Halts HIV Drug Price Hikes Amidst Growing Scrutiny and Public Pressure

Is the Healthcare Sector Primed for a Powerful Rebound?

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access

Beyond COVID: mRNA Vaccines Unleash a New Weapon Against Cancer's Toughest Foes

A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025

A New Dawn for Breast Cancer Treatment: Roche's Gedatolisib and Giredestrant Combination Shows Promise

Nektar Therapeutics Stock Soars Amid Intense Takeover Speculation

FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development

Roche's Bold Leap: Pioneering Direct Patient Engagement for Enhanced Care

The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly

Omeros Stock Skyrockets: Novo Nordisk Seals Massive $2.1 Billion Rare Disease Drug Deal

Urgent Health Alert: Abbott Warns of Dangerous Counterfeit Amoxyclav Batches Circulating in India

Skyrocketing Health Costs: How Pricey New Drugs Are Driving an 8.5% Premium Hike in 2026

Abbott Labs Faces Mixed Fortunes in Q3: Revenue Missed, But Earnings & Future Outlook Impress

North Carolina's Biotech Boom: Powering the Future of Medicine Through Advanced Manufacturing

Telangana's Landmark Move: Mandatory Testing for Deadly Contaminants in All Syrups to Secure Public Health

Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI

Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape

Johnson & Johnson Soars: Q3 Earnings Crush Expectations, Full-Year Forecast Skyrockets!

Johnson & Johnson's Bold Orthopedics Spin-Off: A New Era of Growth and Value Unveiled

Johnson & Johnson Soars: Beating Q3 Expectations and Raising Full-Year Outlook

J&J's Q3 Rollercoaster: Stock Dip, MedTech Hopes, and Tariff Tangles!

Under Siege: Whistleblowers Unmask Political Pressures Threatening FDA's Scientific Soul

Urgent Global Health Alert: WHO Flags Contaminated Cough Syrups in India

The Production Predicament: How Manufacturing Woes Threaten Novo Nordisk's Blockbuster Drugs

The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market

AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement

Revolutionizing Healthcare: Trump's Bold Stance on Lowering Prescription Drug Costs

President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Rubicon Research IPO Draws Strong Investor Interest, Nearing Full Subscription on Day 2

The Silent Storm: Why Our Conversations About Antibiotic Resistance Need a Radical Overhaul

Boston-Cambridge: The Unrivaled Epicenter of Global Biotech Innovation

Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow

Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future

Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal

Unlocking Cures: The Pharmaceutical Industry's Toughest Battle in the Global South

A Deadly Divide: WHO Unmasks Critical Flaw in India's Domestic Cough Syrup Testing